Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
Shaima’a Hamarsheh, Robert Zeiser
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 184

Showing 1-25 of 184 citing articles:

Immune modulatory effects of oncogenic KRAS in cancer
Shaima’a Hamarsheh, Olaf Groß, Tilman Brummer, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 273
The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases
Hallie Blevins, Yiming Xu, Savannah Biby, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 262
NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation
Liudmila Andreeva, Liron David, Shaun Rawson, et al.
Cell (2021) Vol. 184, Iss. 26, pp. 6299-6312.e22
Open Access | Times Cited: 189
The Hallmarks of Flavonoids in Cancer
Luis Gustavo Saboia Ponte, Isadora Carolina Betim Pavan, Mariana Camargo Silva Mancini, et al.
Molecules (2021) Vol. 26, Iss. 7, pp. 2029-2029
Open Access | Times Cited: 115
Context-dependent functions of pattern recognition receptors in cancer
Si Ming Man, Brendan J. Jenkins
Nature reviews. Cancer (2022) Vol. 22, Iss. 7, pp. 397-413
Closed Access | Times Cited: 84
β2-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression
Daniel Hofbauer, Dimitrios Mougiakakos, Luca Broggini, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1772-1787.e9
Open Access | Times Cited: 71
NLRP3 Ubiquitination—A New Approach to Target NLRP3 Inflammasome Activation
Mahbuba Akther, Md. Ezazul Haque, Jooho Park, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8780-8780
Open Access | Times Cited: 67
The Role of Purinergic P2X7 Receptor in Inflammation and Cancer: Novel Molecular Insights and Clinical Applications
John Charles Rotondo, Chiara Mazziotta, Carmen Lanzillotti, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1116-1116
Open Access | Times Cited: 65
NF-κB: A Double-Edged Sword Controlling Inflammation
Danhui Liu, Zhenyu Zhong, Michael Karin
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1250-1250
Open Access | Times Cited: 63
The Role of Decorin and Biglycan Signaling in Tumorigenesis
Valentina Diehl, Lisa Sophie Huber, Jonel Trebicka, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 62
Lactic Acid Fermentation Is Required for NLRP3 Inflammasome Activation
Hsin‐Chung Lin, Yu-Jen Chen, Yau–Huei Wei, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 57
The Effect of Ketogenic Diet on Shared Risk Factors of Cardiovascular Disease and Cancer
Noushin Mohammadifard, Fahimeh Haghighatdoost, Mehran Rahimlou, et al.
Nutrients (2022) Vol. 14, Iss. 17, pp. 3499-3499
Open Access | Times Cited: 49
The Role of Post-Translational Modifications in Regulation of NLRP3 Inflammasome Activation
Jing Xia, Songhong Jiang, Shiqi Dong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6126-6126
Open Access | Times Cited: 39
Divergent functions of NLRP3 inflammasomes in cancer: a review
Alireza Shadab, Mohamad Mahjoor, Mohammad Abbasi‐Kolli, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 33
An IL-1β-driven neutrophil–stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma
Madelon M.E. de Jong, Cathelijne Fokkema, Natalie Papazian, et al.
Nature Immunology (2024) Vol. 25, Iss. 5, pp. 820-833
Closed Access | Times Cited: 11
The critical role of NLRP3 in drug resistance of cancers: Focus on the molecular mechanisms and possible therapeutics
Beena Briget Kuriakose, Ahmed Hussein Zwamel, Ayad Abdulrazzaq Mutar, et al.
Seminars in Oncology (2025) Vol. 52, Iss. 1, pp. 27-40
Closed Access | Times Cited: 1
DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma
Allison A. Fitzgerald, Shangzi Wang, Veena R. Agarwal, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 11, pp. e002837-e002837
Open Access | Times Cited: 51
Low NLRP3 expression predicts a better prognosis of colorectal cancer
Feng Shi, Bo Wei, Tian Lan, et al.
Bioscience Reports (2021) Vol. 41, Iss. 4
Open Access | Times Cited: 48
Cell Death in Hepatocellular Carcinoma: Pathogenesis and Therapeutic Opportunities
Ester García-Pras, Anabel Fernández‐Iglesias, Jordi Gracia‐Sancho, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 48-48
Open Access | Times Cited: 47
CHIP Happens: Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors
Sarah C. Reed, Sarah Croessmann, Ben Ho Park
Clinical Cancer Research (2022) Vol. 29, Iss. 8, pp. 1403-1411
Open Access | Times Cited: 38
Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy
Su Zhang, Yang Meng, Lian Zhou, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 35
Inflammasomes in Cancer Progression and Anti-Tumor Immunity
Sebastian Lillo, Maya Saleh
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 34
Role of Inflammasomes in Keloids and Hypertrophic Scars—Lessons Learned from Chronic Diabetic Wounds and Skin Fibrosis
Chenyu Huang, Rei Ogawa
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6820-6820
Open Access | Times Cited: 33
Aluminium Nanoparticles as Efficient Adjuvants Compared to Their Microparticle Counterparts: Current Progress and Perspectives
Ali Nazarizadeh, Alexander H. Staudacher, Nicole L. Wittwer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4707-4707
Open Access | Times Cited: 30
Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer
Jashodeep Datta, Anna Bianchi, Iago De Castro Silva, et al.
Oncogene (2022) Vol. 41, Iss. 28, pp. 3640-3654
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top